Alaunos Therapeutics, Inc. Accrued Liabilities, Current
Alaunos Therapeutics, Inc. (TCRT) had Accrued Liabilities, Current of $132.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Accrued Liabilities, Current $132.00K.
- 2026-03-31: Accrued Liabilities, Current $195.00K.
- 2025-12-31: Accrued Liabilities, Current $200.00K.
- 2025-09-30: Accrued Liabilities, Current $78.00K.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $132.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $195.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $200.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $78.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $265.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $231.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $176.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $368.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $542.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $643.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $1.34M 10-K · filed 2025-03-31 |
| 2023-09-30 | $3.07M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $3.23M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $4.12M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $5.45M 10-K · filed 2024-04-01 |
| 2022-09-30 | $7.67M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $5.72M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $5.89M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $6.08M 10-K · filed 2023-03-07 |
| 2021-09-30 | $13.96M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $11.85M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $14.01M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $16.59M 10-K · filed 2022-03-30 |
| 2020-09-30 | $15.84M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $15.19M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $15.36M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $10.85M 10-K · filed 2021-03-01 |
| 2019-09-30 | $9.57M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $8.80M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $6.84M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $8.76M 10-K · filed 2020-03-02 |
| 2018-09-30 | $9.38M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $8.66M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $8.88M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $9.91M 10-K · filed 2019-03-05 |
| 2017-09-30 | $10.11M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $9.35M 10-Q · filed 2017-07-31 |
| 2017-03-31 | $10.69M 10-Q · filed 2017-05-01 |
| 2016-12-31 | $9.11M 10-K · filed 2018-03-01 |
| 2016-09-30 | $7.36M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $7.39M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $8.58M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $8.91M 10-K · filed 2017-02-16 |
| 2015-09-30 | $18.14M 10-Q · filed 2015-11-02 |
| 2015-06-30 | $8.75M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $8.22M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $7.18M 10-K · filed 2016-02-24 |
| 2014-09-30 | $7.80M 10-Q · filed 2014-10-30 |
| 2014-06-30 | $7.77M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $5.75M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $6.36M 10-K · filed 2015-02-26 |
| 2013-09-30 | $11.57M 10-Q · filed 2013-10-22 |
| 2013-06-30 | $18.97M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $18.52M 10-Q · filed 2013-05-07 |
| 2012-12-31 | $16.52M 10-K · filed 2014-03-03 |
| 2012-09-30 | $16.68M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $15.50M 10-Q/A · filed 2012-08-28 |
| 2012-03-31 | $11.53M 10-Q · filed 2012-05-03 |
| 2011-12-31 | $10.82M 10-K · filed 2013-03-18 |
| 2011-09-30 | $8.79M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $6.08M 10-Q/A · filed 2011-08-09 |
| 2010-12-31 | $2.54M 10-K · filed 2012-02-29 |
| 2010-09-30 | $2.98M 10-Q · filed 2011-08-01 |
| 2009-12-31 | $1.26M 10-Q · filed 2011-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |